Close

Lorvotuzumab mertansine (TAB-188)

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human CD56 Therapeutic Antibody TAB-188 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant monoclonal antibody to CD56. Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate of lorvotuzumab linked to mertansine intended for CD56 positive cancers (e.g. small-cell lung cancer, ovarian cancer).
  • Target
  • CD56
  • Type
  • IgG1 - kappa
  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods.
  • CAS
  • 1008106-64-6
  • Specificity
  • Tested positive against native human antigen.
  • Predicted N terminal
  • H chain: QVQLVES; L chain: DVVMTQS
  • Molecular Weight
  • 146433
  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Size
  • 1mg
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

BACKGROUND

  • Antigen Description
  • This protein is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc.
  • Synonyms
  • NCAM1; neural cell adhesion molecule 1; CD56; NCAM; neural cell adhesion molecule, NCAM; antigen recognized by monoclonal 5.1H11; MSK39;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us